Karl Keegan
Director/Board Member bei Novai Ltd.
Profil
Karl David Keegan currently works at Novai Ltd., as Non-Executive Director and Singer Capital Markets Securities Ltd., as Life Science Analyst from 2022.
Dr. Keegan also formerly worked at Hox Therapeutics Ltd., as Chief Executive Officer & Director, Conroy Gold & Natural Resources Plc, as Independent Non-Executive Director from 2017 to 2018, Canaccord Adams Ltd., as Managing Director & Head-Research Division in 2009, Shield Therapeutics Plc, as CFO & Director-Corporate Development from 2017 to 2018, Nuformix Plc, as Senior Independent Non-Executive Director from 2020 to 2021, UBS AG, as Biotechnolgy Analyst, Canaccord Genuity Group, Inc., as Global Sector Head-Life Sciences Research, Vectura Group Ltd., as Chief Corporate Development Officer from 2014 to 2016, e-Therapeutics Plc, as Chief Financial Officer in 2021, Minster Pharmaceuticals Plc, as Chief Financial Officer in 2010, Pharming Group NV, as CFO & Member-Management Board from 2010 to 2012, Dresdner Kleinwort Benson Equity, as Biotechnology Analyst, and Banc of America Specialist, Inc., as Biotechnolgy Analyst.
Dr. Keegan received his graduate degree and doctorate degree from the University of Cambridge, undergraduate degree in 1988 from University College Dublin, and graduate degree from London Business School.
Aktive Positionen von Karl Keegan
| Unternehmen | Position | Beginn |
|---|---|---|
Novai Ltd.
 Novai Ltd. Miscellaneous Commercial ServicesCommercial Services Novai Ltd. operates as a biotechnology company. It offers gene therapies, clinical research, optimize drug development services. The company was founded by Maria Francesca Cordeiro on February 12, 2020 and is headquartered in Reading, the United Kingdom. | Director/Board Member | - |
Singer Capital Markets Securities Ltd.
 Singer Capital Markets Securities Ltd. Investment Banks/BrokersFinance Part of N1 Singer Ltd., Singer Capital Markets Securities Ltd. is a brokerage firm. The private company is based in London, UK. The British company was founded in 2012 by Timothy Bruce Cockroft, Peter Welch. Timothy Bruce Cockroft has been the CEO since 2012. | Analyst-Equity | 01.02.2022 |
Ehemalige bekannte Positionen von Karl Keegan
| Unternehmen | Position | Ende |
|---|---|---|
| E-THERAPEUTICS PLC | Director of Finance/CFO | 31.12.2021 |
| NUFORMIX PLC | Director/Board Member | 24.05.2021 |
| CONROY GOLD AND NATURAL RESOURCES PLC | Director/Board Member | 07.12.2018 |
| SHIELD THERAPEUTICS PLC | Director of Finance/CFO | 01.08.2018 |
| VECTURA GROUP | Corporate Officer/Principal | 01.07.2016 |
Ausbildung von Karl Keegan
| University of Cambridge | Doctorate Degree |
| University College Dublin | Undergraduate Degree |
| London Business School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| CANACCORD GENUITY GROUP INC. | Finance |
| E-THERAPEUTICS PLC | Health Technology |
| CONROY GOLD AND NATURAL RESOURCES PLC | Non-Energy Minerals |
| PHARMING GROUP N.V. | Health Technology |
| SHIELD THERAPEUTICS PLC | Health Technology |
| NUFORMIX PLC | Health Technology |
| Private Unternehmen | 9 |
|---|---|
UBS AG
 UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Minster Pharmaceuticals Plc
 Minster Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Minster Pharmaceuticals Plc develops pharmaceutical compounds for the treatment of neurological and psychiatric conditions. The company operates in Tonabersat and Sabcomeline segments. The Tonabersat segment is for the prevention and treatment of migraine. The Sabcomeline segment is for the management of cognitive decline and negative symptoms in schizophrenia. Minster Pharmaceuticals was founded by Robert Stubbs and Paul Sharpe in 2001 and is headquartered in London, the United Kingdom. | Health Technology |
| Canaccord Adams Ltd. | Finance |
| Dresdner Kleinwort Benson Equity | |
Banc of America Specialist, Inc.
 Banc of America Specialist, Inc. Investment Banks/BrokersFinance Banc of America Specialist, Inc. is an SEC-registered broker/dealer located in New York City. The firm is a subsidiary of NB Holdings Corp. Their ultimate parent is Bank of America Corp. (NYSE: BAC). Banc of America Specialist provides securities services on the New York Stock Exchange and assists with IPOs. The firm follows S&P 500 companies in several sectors including financial services, energy, consumer products, retail and telecommunications. Banc of America Specialist was originally founded in 1982 as Quick & Reilly Specialist, ultimately incorporating Conklin, Cahill & Co. and Colin Hockstin & Co. From 1990 until 1995, the firm acquired three prestigious specialist firms: Murphy, Marseilles Smith & Nammack, Stokes Hoyt & Co and Pforzheimer/Drexel Burnham Specialists. In 1995, Quick & Reilly Specialist was renamed JJC Specialist. In 1998, JJC Specialist was purchased by Fleet Boston Financial, which also acquired Merrill Lynch Specialist, and the firm was renamed Fleet Specialist. In 2000, FleetBoston Financial acquired MJ Meehan and merged the operations into Fleet Specialist. In 2004, Bank of America acquired FleetBoston Financial and Fleet Specialist became known as Banc of America Specialist, Inc. | Finance |
Singer Capital Markets Securities Ltd.
Singer Capital Markets Securities Ltd. Investment Banks/BrokersFinance Part of N1 Singer Ltd., Singer Capital Markets Securities Ltd. is a brokerage firm. The private company is based in London, UK. The British company was founded in 2012 by Timothy Bruce Cockroft, Peter Welch. Timothy Bruce Cockroft has been the CEO since 2012. | Finance |
Hox Therapeutics Ltd.
 Hox Therapeutics Ltd. BiotechnologyHealth Technology Hox Therapeutics Ltd. develops therapeutics for cancer diseases based on the role of HOX genes. The private company is based in Guildford, UK. | Health Technology |
Novai Ltd.
Novai Ltd. Miscellaneous Commercial ServicesCommercial Services Novai Ltd. operates as a biotechnology company. It offers gene therapies, clinical research, optimize drug development services. The company was founded by Maria Francesca Cordeiro on February 12, 2020 and is headquartered in Reading, the United Kingdom. | Commercial Services |
